Age: 57 Director Since: 2015 Board Committees: Chair Science and Technology Committee Member Corporate Governance and Nominating Committee Experience: Other Public Company Boards: None John J. and Dorothy Wilson Professor of Health Sciences & Technology/Electrical Engineering & Computer Science at the Massachusetts Institute of Technology ( MIT ) since 2005; Director of the Marble Center for Cancer Nanomedicine at the Koch Institute for Integrative Cancer Research at MIT since 2016; Investigator of the Howard Hughes Medical Institute at MIT since 2008 Co-Founder of Ropirio Therapeutics, a private biotechnology company focused on lymphatic medicine, since 2023 Co-Founder of Amplifyer Bio, a private biotechnology company focused on oncology diagnostics, since 2023 Co-Founder of Matrisome Bio, a private biotechnology company, since 2023 Co-Founder of Port Therapeutics, a private company focused on thermal bioswitches in oncology, since 2022 Co-Founder of Satellite Bio, a private company focused on developing satellite organs as living therapeutic solutions, since 2020 Co-Founder of Glympse Bio, a private company focused on developing in vivo sensing technology dedicated to disease monitoring, from 2018 until it was acquired by Sunbird Bio, Inc. in August 2023 Professor of bioengineering and medicine at the University of California at San Diego, from 1998 through 2005 Member of the Department of Medicine at Brigham and Women s Hospital and member of the Broad Institute Holds a Sc.B. in biomedical engineering from Brown University, an S.M. and Ph.D. in Mechanical Engineering from MIT, and an M.D. from Harvard Medical School Key Skills and Qualifications: Dr. Bhatia is a leading academic scientist and medical researcher. Her extensive experience in the field of biomedical engineering and in-depth understanding on the use of advanced technologies in medical research provide valuable insights to our board of directors, including with respect to our key research and development initiatives.